Tweet
Bournemouth Echo |
Deal by Cystic Fibrosis Foundation Raises Cash and Some Concern New York Times Robert J. Beall, chief executive of the Cystic Fibrosis Foundation, which helped finance the development of a treatment. Credit T.J. Kirkpatrick for The New York Times. Continue reading the main story. Continue reading the main story. Continue reading the ... Royalty Pharma Announces $3.3 Billion Royalty Transaction with Cystic Fibrosis ...Businessweek Is the CF Foundation's $3.3B royalty windfall good or bad for patients?FierceBiotech Royalty Pharma buys royalties on Vertex Pharma drugs for $3.3 blnReuters Worcester Telegram -MarketWatch -Nasdaq all 28 news articles » |
More...